Exhibit 10.22


 


“Unofficial
English Translation from Hebrew”


 


Addendum
to the Convertible Loan Agreement of the 20th of March 2016


 


Which
was written and signed on the 30th of March 2016


 


	By
    and between:	Rimon
    Gold Assets Ltd.
	 	Co.
    no. 514819424
	 	32
    A Habarzel St. Tel Aviv
	 	(hereinafter
    the “Lender”)


 


Of
the first part;


 


	And:	Wize
    Pharma Ltd.
	 	Co.
    no. 520033259
	 	2
    Hamenofim St. Herzliya
	 	(hereinafter
    the “Company”)


 


Of
the second part;


 


	Whereas:	On
    the 20th of March 2016 the parties signed a convertible loan agreement (hereinafter the “Agreement”);
	 	 
	And
    whereas:	In
    the framework of the agreement the parties arranged the legal and commercial relationship between them with respect to the
    loan (as defined in the agreement);
	 	 
	And
    whereas:	The
    parties wish to amend the provisions of the agreement in the manner set forth hereafter.


 


Therefore,
it was declared, stipulated and agreed by and between the parties as follows:


 


	1.	The
                                         Introduction and Titles



 


		1.1.	The
                                         preamble of this addendum constitutes an integral part of it.
	 	 	 
		1.2.	The
                                         titles of this addendum are for convenience only and they will not bind or serve for
                                         the interpretation of this addendum.
	 	 	 
		1.3.	All
                                         the definitions and terms determined in the agreement will apply respectively to this
                                         addendum, unless it was stated otherwise.



 


	2.	Amendment
                                         of the Provisions of the Agreement



 


The
parties hereby agree that in lieu of the provisions set forth in the agreement, the following provisions will apply:


 


		2.1.	The
                                         provisions in sections 4.6 (1), 4.6 (2) and 4.6 (3) of the agreement will be deleted.



 






     


     


    

 


		2.2.	At
                                         the end of section 9.5 of the agreement the following sentence will be added:



 


“Furthermore,
the company will not offer to its shareholders by way of rights, rights to purchase any securities”.


 


	3.	Miscellaneous



 


		3.1.	This
                                         addendum constitutes an integral part of the agreement.
	 	 	 
		3.2.	Except
                                         for the express statements in this addendum above, no changes will apply to the other
                                         provisions of the agreement and they will continue to apply in their order.
	 	 	 
		3.3.	In
                                         any event of a contradiction between the provisions of this addendum and the provisions
                                         of the agreement, the provisions of this addendum will prevail, unless it was mentioned
                                         otherwise.



 


And
we have hereby signed hereafter:


 


	/s/
    Or Eisenberg	 	/s/
    Abir Raveh
	Wize
                                         Pharma Ltd.

        Date:
        30/3/16

        Address:   2   Hamenofim
        St.

        Herzliya

        To:
        Or Eisenberg, CEO

        Fax:
        072- 2600537

        Email:
        or@wizepharma.com
	 	Rimon
                                         Gold Assets Ltd.

        Date:
        30/3/16

        Address:
        32 A Habarzel

        Tel
        Aviv

        To:
        Accountant Abir Raveh

        Fax:
        03- 7676990

        Email:
        Abir@raveh-ravid.co.il